UK markets closed

Arbutus Biopharma Corporation (0SGC.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
2.7093-0.0157 (-0.58%)
At close: 05:32PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.09
52-week change 3-7.00%
S&P500 52-week change 322.36%
52-week high 33.1400
52-week low 30.0000
50-day moving average 32.4452
200-day moving average 32.3474

Share statistics

Avg vol (3-month) 31.41k
Avg vol (10-day) 32.48k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8115.8M
% held by insiders 123.34%
% held by institutions 143.92%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-956.64%

Management effectiveness

Return on assets (ttm)-28.70%
Return on equity (ttm)-59.99%

Income statement

Revenue (ttm)18.14M
Revenue per share (ttm)0.11
Quarterly revenue growth (yoy)-65.70%
Gross profit (ttm)N/A
EBITDA -76.63M
Net income avi to common (ttm)-72.85M
Diluted EPS (ttm)-0.7050
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)126M
Total cash per share (mrq)0.7
Total debt (mrq)8.72M
Total debt/equity (mrq)8.23%
Current ratio (mrq)5.87
Book value per share (mrq)0.62

Cash flow statement

Operating cash flow (ttm)-85.94M
Levered free cash flow (ttm)-51.58M